MA1Y

ICD-11 MMS 2026-01

Other specified clinical findings in blood, blood-forming organs, or the immune system

Exclusions from above levels

  • 3B64 – Thrombocytopenia
  • http://id.who.int/icd/entity/1016799900 – abnormalities of coagulation
  • http://id.who.int/icd/entity/1191191920 – abnormalities of lipids
Show allHide
  • http://id.who.int/icd/entity/1800910986 – Haemorrhagic or haematological disorders of fetus or newborn
  • JA66.0 – Abnormal haematological finding on antenatal screening of mother
  • 19 – Certain conditions originating in the perinatal period
  • JA66 – Clinical findings on antenatal screening of mother

Sibling codes

  • MA10 – Abnormal serum enzyme levels
  • MA11 – Clinical findings of hormones in blood, blood-forming organs, or the immune system
  • MA12 – Clinical findings of drugs, medicaments or biological substances in blood, blood-forming organs, or the immune system
  • MA13 – Clinical findings of substances chiefly nonmedicinal as to source in blood, blood-forming organs, or the immune system
  • MA14 – Immunological findings in blood, blood-forming organs, or the immune system
  • MA15 – Microbiological findings in blood, blood-forming organs, or the immune system
  • MA16 – Cytological findings in blood, blood-forming organs, or the immune system
  • MA17 – Histological findings in blood, blood-forming organs, or the immune system
  • MA18 – Certain clinical findings of blood chemistry
  • MA19 – Certain abnormalities of plasma proteins
  • MA1A – Elevated erythrocyte sedimentation rate or abnormality of plasma viscosity

Foundation entity

Clinical findings in blood, blood-forming organs, or the immune system – http://id.who.int/icd/entity/1617090159

Part of: 21: Symptoms, signs or clinical findings, not elsewhere classified